...
首页> 外文期刊>The Journal of Antimicrobial Chemotherapy >Emergence of multidrug-resistant Salmonella enterica serotype 4,[5],12:i:- involving human cases in Canada: results from the Canadian Integrated Program on Antimicrobial Resistance Surveillance (CIPARS), 2003-10
【24h】

Emergence of multidrug-resistant Salmonella enterica serotype 4,[5],12:i:- involving human cases in Canada: results from the Canadian Integrated Program on Antimicrobial Resistance Surveillance (CIPARS), 2003-10

机译:多药耐药肠炎沙门氏菌血清型4 [5],12:i:-在加拿大涉及人类病例:加拿大抗菌素耐药性综合监测计划(CIPARS),2003-10年的结果

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Over the last decade, a marked increase in Salmonella enterica serotype 4,[5],12:i:- with a core resistance to ampicillin, streptomycin, sulphonamides and tetracycline (ASSuT) has been observed in Europe. This study describes the emergence and characterization of isolates of multidrug-resistant Salmonella 4,[5],12:i:- in Canada.
机译:在过去的十年中,在欧洲已观察到​​肠沙门氏菌血清型4 [5],12:i:-显着增加,对氨苄西林,链霉素,磺酰胺和四环素(ASSuT)具有核心耐药性。这项研究描述了耐多药沙门氏菌4,[5],12:i:-在加拿大的分离株的出现和特征。

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号